Frequency Therapeutics, Inc. (FREQ) Tops Q2 EPS by 6c

Frequency Therapeutics, Inc. (NASDAQ: FREQ) reported Q2 EPS of ($0.30), $0.06 better than the analyst estimate of ($0.36).

For earnings history and earnings-related data on Frequency Therapeutics, Inc. (FREQ) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Newton Golf Company (NWTG) Reports Q2 Loss of $0.49
• Boost Run, Inc. (BRUN) Reports Q2 Revenue of $31.1M